Brief: Werewolf Therapeutics Reports Quarterly Loss Per Share Of $3.82
12/08/2021 13:39
Aug 12 (Reuters) - Werewolf Therapeutics Inc HOWL.O :
* WEREWOLF THERAPEUTICS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS
TO ENABLE FUNDING OF OPERATING EXPENSES & CAPEX REQUIREMENTS
THROUGH AT LEAST Q2 OF 2023
* WEREWOLF THERAPEUTICS INC QTRLY LOSS PER SHARE $3.82
Further company coverage: HOWL.O
((Reuters.Briefs@thomsonreuters.com;))